Search for Clinical Trial Results

Sponsored By

Lymphomatoid Granulomatosis - 10 Studies Found

Status Study
Completed Study Name: Treatment and Natural History Study of Lymphomatoid Granulomatosis
Condition:
  • Lymphomatoid Granulomatosis
  • Granulomatosis, Lymphomatoid
    • <
    Date: 1999-11-03
    Interventions:
    • Biological: Interferon For LYG
Recruiting Study Name: Tissue Collection for Studies of Lymph Cancer
Condition:
  • Hodgkin Disease
  • Lymphoma, Non-Hodgkin
  • Multiple Myeloma Date: 2012-08-29
Completed Study Name: Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma
Condition:
  • Adult Grade III Lymphomatoid Granulomatosis
  • Adult Nasal Type Ex
    Date: 2007-04-09
    Interventions:
    • Biological: bevacizumab Given

Completed Study Name: FAU in Treating Patients With Advanced Solid Tumors or Lymphoma
Condition:
  • Adult Grade III Lymphomatoid Granulomatosis
  • Adult Nasal Type Ex
    Date: 2008-10-08
    Interventions:
    • Drug: 2'-F-ara-deoxyuridine Gi
Completed Study Name: Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction
Condition:
  • Adult Grade III Lymphomatoid Granulomatosis
  • Adult Nasal Type Ex
    Date: 2007-07-10
    Interventions:
    • Drug: vorinostat Given orally
Terminated Study Name: SB-715992 in Treating Patients With Metastatic or Unresectable Solid Tumors or Hodgkin's or Non-Hodgkin's Lymphoma
Condition:
Date: 2025-11-04
Terminated Study Name: Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas
Condition:
  • Adult Grade III Lymphomatoid Granulomatosis
  • AIDS-related Periph
    Date: 2004-11-09
    Interventions:
    • Drug: tanespimycin Given IV
Completed Study Name: Bortezomib in Treating Patients With Advanced Cancer and Kidney Dysfunction
Condition:
  • Adult Grade III Lymphomatoid Granulomatosis
  • Adult Nasal Type Ex
    Date: 2003-02-05
    Interventions:
    • Drug: bortezomib Given IV
Terminated Study Name: Etoposide, Filgrastim, and Plerixafor in Improving Stem Cell Mobilization in Treating Patients With Non-Hodgkin Lymphoma
Condition:
  • Adult Acute Lymphoblastic Leukemia in Remission
  • Adult Grade III Lympho
    Date: 2011-08-01
    Interventions:
    • Drug: plerixafor Given SC
COMPLETED Study Name: Treatment and Natural History Study of Lymphomatoid Granulomatosis
Condition: Lymphomatoid Granulomatosis
Date: 2025-11-04
Interventions: For LYG Grade 1 and 2: Interferon starting at 7.5 million Units subQ 3 times a week and increasing on the following schedule: 10 million U; 15 million